Emmanuel M.
- Country
- France
- Department
- #2102:Equipe de gastroentérologie, hépatologie, nutrition et maladies héréditaires du métabolisme
Research Overview
- A Phase 3, Multi-Center Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Risankizumab with Open-Label Induction, Randomized Double-Blind Maintenance, and Long-Term Extension Periods in Pediatric Subjects (2 to < 18 Years of Age) with Moderately to Severely Active Crohn's Disease
- Evaluation of Long-term Safety and Tolerability of Inclisiran in Patients with Heterozygous or Homozygous Familial Hypercholesterolemia Post-ORION-16/13 Studies
- Evaluation of Efficacy and Safety of Oral Ozanimod in Pediatric Patients with Moderately to Severely Active Ulcerative Colitis Unresponsive to Conventional Therapy
Data & Insights
Has run more than one trial at 22 of 100 partner sites.
Specializations
Inflammatory Bowel Disease Management
This investigator specializes in treating pediatric inflammatory bowel diseases, with particular focus on both Crohn's disease and ulcerative colitis. Their research encompasses innovative therapeutic approaches for moderately to severely active cases in young patients.
- Ozanimod therapy in pediatric IBD
- Guselkumab treatment for ulcerative colitis
- Risankizumab applications in Crohn's disease
Their work focuses on patients who have shown inadequate response to conventional therapies.
Metabolic Disorders
The investigator conducts research in the treatment of genetic metabolic conditions, particularly focusing on familial hypercholesterolemia in both heterozygous and homozygous forms.
- Long-term management of familial hypercholesterolemia
- Inclisiran therapy in adolescent patients
Their research emphasizes long-term safety and tolerability in younger patient populations.
Genetic Disorders
This investigator studies inherited gastrointestinal conditions, specifically familial adenomatous polyposis, exploring novel therapeutic approaches for adolescent patients.
- Rapamycin treatment protocols
- Safety profiling in adolescent FAP patients
Their research focuses on developing safe and effective treatment options for young patients with genetic predispositions to colorectal conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.